26.15 USD
+0.03 (+0.11%)
At close: Jan 29, 2026
26.15 USD
0 (0%)
After Hours: 1/29/2026, 8:00:00 PM
Taking everything into account, AMPH scores 6 out of 10 in our fundamental rating. AMPH was compared to 190 industry peers in the Pharmaceuticals industry. AMPH has an excellent profitability rating, but there are some minor concerns on its financial health. AMPH is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make AMPH a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- AMPH had positive earnings in the past year.
- AMPH had a positive operating cash flow in the past year.
- AMPH had positive earnings in each of the past 5 years.
- Each year in the past 5 years AMPH had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 6.70%, AMPH belongs to the top of the industry, outperforming 87.89% of the companies in the same industry.
- The Return On Equity of AMPH (14.37%) is better than 88.42% of its industry peers.
- AMPH has a Return On Invested Capital of 8.51%. This is amongst the best in the industry. AMPH outperforms 86.84% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for AMPH is in line with the industry average of 12.83%.
- The last Return On Invested Capital (8.51%) for AMPH is well below the 3 year average (12.92%), which needs to be investigated, but indicates that AMPH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.7% | ||
| ROE | 14.37% | ||
| ROIC | 8.51% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
- With an excellent Profit Margin value of 15.43%, AMPH belongs to the best of the industry, outperforming 87.37% of the companies in the same industry.
- In the last couple of years the Profit Margin of AMPH has grown nicely.
- Looking at the Operating Margin, with a value of 20.73%, AMPH belongs to the top of the industry, outperforming 87.89% of the companies in the same industry.
- AMPH's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 49.36%, AMPH is doing good in the industry, outperforming 64.21% of the companies in the same industry.
- AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.73% | ||
| PM (TTM) | 15.43% | ||
| GM | 49.36% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
- AMPH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- AMPH has less shares outstanding than it did 1 year ago.
- AMPH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AMPH has an improved debt to assets ratio.
2.2 Solvency
- AMPH has an Altman-Z score of 2.39. This is not the best score and indicates that AMPH is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.39, AMPH is in the better half of the industry, outperforming 63.68% of the companies in the same industry.
- The Debt to FCF ratio of AMPH is 5.49, which is a neutral value as it means it would take AMPH, 5.49 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 5.49, AMPH belongs to the top of the industry, outperforming 82.11% of the companies in the same industry.
- AMPH has a Debt/Equity ratio of 0.78. This is a neutral value indicating AMPH is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.78, AMPH is not doing good in the industry: 70.53% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 5.49 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.95
WACC8.96%
2.3 Liquidity
- AMPH has a Current Ratio of 3.12. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of AMPH (3.12) is comparable to the rest of the industry.
- A Quick Ratio of 2.21 indicates that AMPH has no problem at all paying its short term obligations.
- AMPH has a Quick ratio (2.21) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.12 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
- AMPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.95%.
- AMPH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 61.62% yearly.
- Looking at the last year, AMPH shows a decrease in Revenue. The Revenue has decreased by -0.03% in the last year.
- AMPH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.82% yearly.
EPS 1Y (TTM)-9.95%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%-3.12%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%0.33%
3.2 Future
- AMPH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.14% yearly.
- Based on estimates for the next years, AMPH will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-8.73%
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
EPS Next 5Y0.14%
Revenue Next Year-0.8%
Revenue Next 2Y1.99%
Revenue Next 3Y2.7%
Revenue Next 5Y4.14%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 7.60, the valuation of AMPH can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 93.16% of the companies listed in the same industry.
- AMPH is valuated cheaply when we compare the Price/Earnings ratio to 28.39, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 7.04, which indicates a rather cheap valuation of AMPH.
- AMPH's Price/Forward Earnings ratio is rather cheap when compared to the industry. AMPH is cheaper than 92.63% of the companies in the same industry.
- AMPH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.6 | ||
| Fwd PE | 7.04 |
4.2 Price Multiples
- AMPH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMPH is cheaper than 91.05% of the companies in the same industry.
- 90.00% of the companies in the same industry are more expensive than AMPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.82 | ||
| EV/EBITDA | 7.28 |
4.3 Compensation for Growth
- The excellent profitability rating of AMPH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
5. Dividend
5.1 Amount
- AMPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
What is the fundamental rating for AMPH stock?
ChartMill assigns a fundamental rating of 6 / 10 to AMPH.
What is the valuation status of AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?
ChartMill assigns a valuation rating of 8 / 10 to AMPHASTAR PHARMACEUTICALS IN (AMPH). This can be considered as Undervalued.
Can you provide the profitability details for AMPHASTAR PHARMACEUTICALS IN?
AMPHASTAR PHARMACEUTICALS IN (AMPH) has a profitability rating of 9 / 10.
What is the valuation of AMPHASTAR PHARMACEUTICALS IN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 7.6 and the Price/Book (PB) ratio is 1.55.